Fabino Enterprises (BOM:543444) EBIT: ₹-6.1 Mil (TTM As of Mar. 2026)


BOM:543444 Fabino Enterprises Ltd BOM:543444
68 GF Score
Price ₹20.31
GF Value ₹37.57
! 5 Warning Signs
View Full Analysis

What is Fabino Enterprises EBIT?

Fabino Enterprises BOM:543444 68 EBIT is ₹-6.1 Mil as of Mar. 2026. GuruFocus rates BOM:543444 with a GF Score™ of 68/100 and a GF Value™ of ₹37.57. The stock has 5 warning signs investors should review.

Fabino Enterprises's earnings before interest and taxes (EBIT) for the six months ended in Mar. 2026 was ₹-5.1 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹-6.1 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Fabino Enterprises's annualized ROC % for the quarter that ended in Mar. 2026 was -43.02%. Fabino Enterprises's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was -21.83%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Fabino Enterprises's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was -10.64%.

Fabino Enterprises  (BOM:543444) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Fabino Enterprises's annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Sep. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=-35.932 * ( 1 - 32.49% )/( (58.052 + 54.722)/ 2 )
=-24.2576932/56.387
=-43.02 %

where

Invested Capital(Q: Sep. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=153.015 - 92.783 - ( 2.18 - max(0, 95.249 - 148.08+2.18))
=58.052

Invested Capital(Q: Mar. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=221.426 - 164.716 - ( 1.988 - max(0, 168.726 - 215.387+1.988))
=54.722

Note: The Operating Income data used here is two times the semi-annual (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

Fabino Enterprises's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Sep. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-10.162/( ( (4.248 + max(41.895, 0)) + (3.745 + max(43.223, 0)) )/ 2 )
=-10.162/( ( 46.143 + 46.968 )/ 2 )
=-10.162/46.5555
=-21.83 %

where Working Capital is:

Working Capital(Q: Sep. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(129.815 + 7.306 + 0.022999999999996) - (92.783 + 0 + 2.466)
=41.895

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(164.632 + 10.641 + 36.676) - (164.716 + 0 + 4.01)
=43.223

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Mar. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Fabino Enterprises's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2026 )
=-6.057/56.902
=-10.64 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fabino Enterprises EBIT Related Terms

Fabino Enterprises EBIT Historical Data

* Premium members only.

The historical data trend for Fabino Enterprises's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fabino Enterprises EBIT Chart

Fabino Enterprises Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
EBIT
Get a 7-Day Free Trial 0.72 0.21 0.70 3.15 -6.06

Fabino Enterprises Semi-Annual Data
Mar19 Mar20 Mar21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.53 0.99 2.15 -0.98 -5.08

BOM:543444 vs ZTS, UTHR: EBIT Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Fabino Enterprises's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Fabino Enterprises EV-to-EBIT vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Fabino Enterprises's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Fabino Enterprises's EV-to-EBIT falls into.


BOM:543444
68GF Score
Fabino Enterprises Ltd BOM:543444
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Fabino Enterprises EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹-6.1 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of ₹-6.1 Mil mean?
Fabino Enterprises (BOM:543444) has a EBIT of ₹-6.1 Mil as of Mar. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Fabino Enterprises.
Is Fabino Enterprises' EBIT too high?
Fabino Enterprises' current EBIT is ₹-6.1 Mil. Overall, Fabino Enterprises has a GF Score™ of 68/100, reflecting its overall financial health beyond just this single metric.
How does Fabino Enterprises' EBIT compare to ZTS and UTHR?
Fabino Enterprises' EBIT of ₹-6.1 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Drug Manufacturers company?
A good EBIT depends on the Drug Manufacturers industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Fabino Enterprises. Fabino Enterprises's current EBIT is ₹-6.1 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fabino Enterprises stock overvalued right now?
Fabino Enterprises (BOM:543444) has a current EBIT of ₹-6.1 Mil. The stock's GF Value™ is ₹37.57, compared to a current price of ₹20.31 — trading 45.9% below its estimated fair value. The current EBIT is ₹-6.1 Mil. Fabino Enterprises' overall GF Score™ is 68/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Fabino Enterprises (BOM:543444), the current EBIT is ₹-6.1 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Fabino Enterprises (BOM:543444) Overvalued in 2026?

Based on GuruFocus' analysis, Fabino Enterprises stock appears to be undervalued. The current stock price of ₹20.31 is trading 45.9% below its estimated GF Value™ of ₹37.57.

Key valuation signals for BOM:543444:

  • EBIT: ₹-6.1 Mil
  • GF Value™: ₹37.57 vs. price of ₹20.31 (45.9% below fair value)
  • GF Score™: 68/100 with 5 warning signs

No single metric tells the full story. See the BOM:543444 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Fabino Enterprises Business Description

Address Murthal Road, Shubham Garden, Jeevan Vihar Extension Near, Sonipat, HR, IND, 131001
Fabino Enterprises Ltd formerly known as Fabino Life Sciences Ltd is a pharmaceutical company. It is engaged in manufacturing, marketing, trading and packing of pharmaceutical and other wellness-focused consumer products. It offers a wide range of allopathic, Food and wellness, Veterinary, Multi-vitamin and herbal products. The company currently supplies in Haryana, Delhi, parts of Punjab, Himachal Pradesh, Eastern Uttar Pradesh, Orissa, and Jharkhand, and parts of West Bengal, Andhra Pradesh, and Nepal.
68GF Score

Get the complete analysis for BOM:543444

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹20.31
Price
₹37.57
GF Value